HIV :: Imaging techniques reveal that HIV infects host cells using a molecular entry claw

An advanced imaging technique known as electron tomography has allowed researchers at the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to visualize an ?entry claw,? a unique structure formed between the human immunodeficiency virus (HIV) that causes AIDS and the cell it infects. The findings are in the May 4, 2007, issue of PLoS Pathogens.

Genome :: Researchers Publish First Marsupial Genome Sequence

An international team, led by researchers at the Broad Institute of MIT and Harvard and supported by the National Institutes of Health (NIH), today announced the publication of the first genome sequence of a marsupial, belonging to a South American species of opossum.

Dementia :: $30 million boost to dementia research

The funding will ensure the establishment of a world-class facility that will accommodate significantgrowth in the area of dementia research. With this financial support realised, and the initial projectdesign completed, work on this vital development can now move ahead immediately.

Sinusitis :: NIH awards VBI, Mayo Clinic $2.4M to study chronic rhinosinusitis

Virginia Bioinformatics Institute and Virginia Tech biological sciences associate professor Chris Lawrence is teaming up with Mayo Clinic on a $2.4 million project funded by the National Institute of Allergy and Infectious Diseases (NIAID). The work could help researchers develop treatments, diagnostic tools, and preventative measures for patients suffering from chronic rhinosinusitis (CRS).

Meditation :: Meditation may fine-tune control over attention

Everyday experience and psychology research both indicate that paying close attention to one thing can keep you from noticing something else. However, a new study from the University of Wisconsin-Madison suggests that attention does not have a fixed capacity — and that it can be improved by directed mental training, such as meditation.

Stem Cell :: Human embryonic stem cells to achieve vascular repair

Advanced Cell Technology, Inc. (OTCBB: ACTC) reported for the first time that hemangioblast precursor cells derived from human embryonic stem (hES) cells can be used to achieve vascular repair. The research, which appears today online (ahead of print) in the journal Nature Methods, by Advanced Cell Technology (ACT) and its collaborators, describes an efficient method for generating large numbers of bipotential progenitors–known as hemangioblasts–from hES cells that are capable of differentiating into blood vessels, as well as into all blood and immune cell lineages.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack